Skip to main content

Articles

Page 5 of 66

  1. The platelet/high-density lipoprotein cholesterol ratio (PHR) is a novel inflammatory and hypercoagulability marker that represents the severity of metabolic syndrome. Liver metabolic syndrome is manifested by...

    Authors: Chun-feng Lu, Xiao-min Cang, Wang-shu Liu, Li-hua Wang, Hai-yan Huang, Sheng-mei Sang, Xue-qin Wang, Xing-xing Fang and Feng Xu
    Citation: Lipids in Health and Disease 2023 22:130
  2. Epidemiological evidence on the relationship between exposure to volatile organic compounds (VOCs), both single and mixed, and serum lipid levels is limited, and their relationship remains unclear. Our study a...

    Authors: Wen-Yu Chen, Yan-Peng Fu, Hui Tu, Wen Zhong and Liang Zhou
    Citation: Lipids in Health and Disease 2023 22:129
  3. Lipoprotein lipase (LPL) is the rate-limiting enzyme for triglyceride hydrolysis. Homozygous or compound heterozygous LPL variants cause autosomal recessive familial chylomicronemia syndrome (FCS), whereas simple...

    Authors: Guofu Zhang, Yuepeng Hu, Qi Yang, Na Pu, Gang Li, Jingzhu Zhang, Zhihui Tong, Emmanuelle Masson, David N. Cooper, Jian-Min Chen and Weiqin Li
    Citation: Lipids in Health and Disease 2023 22:128
  4. This study aimed to investigate the role of cholesterol metabolism-related genes in nonfunctioning pituitary neuroendocrine tumors (NF-PitNETs) invading the cavernous sinus and analyze the differences in immun...

    Authors: Tianshun Feng, Pengwei Hou, Shuwen Mu, Yi Fang, Xinxiong Li, Ziqi Li, Di Wang, Li Chen, Lingling Lu, Kunzhe Lin and Shousen Wang
    Citation: Lipids in Health and Disease 2023 22:127
  5. Hearing loss is a prevalent health concern, and dietary factors, such as fatty acid intake, may play a role in its development. The current study aimed to investigate the association between the intake of diet...

    Authors: Xiaojin Zhang, Qin Luo, Zhicheng Huang and Xin Xiang
    Citation: Lipids in Health and Disease 2023 22:126
  6. Accumulating evidence indicated that apolipoprotein B (apoB) was the principal lipid determinant of coronary artery disease (CAD). Nevertheless, the connection between apoB and angiographic progression of CAD ...

    Authors: Xing Shui, Zheqi Wen, Ruimin Dong, Zefeng Chen, Leile Tang, Wenyu Tang, Zhen Wu and Lin Chen
    Citation: Lipids in Health and Disease 2023 22:125
  7. Nonalcoholic fatty liver disease (NAFLD) is now the major contributor to chronic liver disease. Disorders of lipid metabolism are a major element in the emergence of NAFLD. This research intended to explore li...

    Authors: Jifeng Liu, Yiming Li, Jingyuan Ma, Xing Wan, Mingjian Zhao, Yunshu Zhang and Dong Shang
    Citation: Lipids in Health and Disease 2023 22:124
  8. The global incidence of nonalcoholic fatty liver disease (NAFLD) is rapidly escalating, positioning it as a principal public health challenge with significant implications for population well-being. Given its ...

    Authors: Rui Meng, Hui Wang, Zhikang Si, Xuelin Wang, Zekun Zhao, Haipeng Lu, Yizhan Zheng, Jiaqi Chen, Huan Wang, Jiaqi Hu, Ling Xue, Xiaoming Li, Jian Sun and Jianhui Wu
    Citation: Lipids in Health and Disease 2023 22:123
  9. Nonpuerperal mastitis (NPM) is a disease that presents with redness, swelling, heat, and pain during nonlactation and can often be confused with breast cancer. The etiology of NPM remains elusive; however, eme...

    Authors: Xiaoxiao Chen, Shijun Shao, Xueqing Wu, Jiamei Feng, Wenchao Qu, Qingqian Gao, Jiaye Sun and Hua Wan
    Citation: Lipids in Health and Disease 2023 22:122
  10. Patients with multi-vessel coronary artery disease (MV-CAD) have poorer clinical outcomes than those with single-vessel coronary artery disease (SV-CAD). Solid evidence underlines that high-density lipoprotein...

    Authors: Jiaqi Chen, Kangxiang Wu, Wanchun Cao, Jianan Shao and Mingyuan Huang
    Citation: Lipids in Health and Disease 2023 22:121
  11. Obesity is often accompanied by metabolic disorder and insulin resistance, resulting in type 2 diabetes. Based on previous findings, FYGL, a natural hyperbranched proteoglycan extracted from the G. lucidum fruiti...

    Authors: YingXin Wang, Fanzhen Yu, Xinru Zheng, Jiaqi Li, Zeng Zhang, Qianqian Zhang, Jieying Chen, Yanming He, Hongjie Yang and Ping Zhou
    Citation: Lipids in Health and Disease 2023 22:120
  12. Lipoprotein lipase (LPL) is the key enzyme responsible for the hydrolysis of triglycerides. Loss-of-function variants in the LPL gene are associated with hypertriglyceridemia (HTG) and HTG-related diseases. Unlik...

    Authors: Yuepeng Hu, Guofu Zhang, Qi Yang, Na Pu, Kaiwei Li, Baiqiang Li, David N. Cooper, Zhihui Tong, Weiqin Li and Jian-Min Chen
    Citation: Lipids in Health and Disease 2023 22:119
  13. This study analyzed the clinical features and biomarkers of alcohol-associated liver disease (ALD) to investigate the diagnostic value of age, bilirubin, international normalized ratio (INR), and creatinine (A...

    Authors: Xiaoqing Jia, Rong Li, Xiaoting Zhang, Tao Zhou, Dalong Sun, Na Yang and Zheng Luo
    Citation: Lipids in Health and Disease 2023 22:117
  14. Endometrial carcinoma (EC) has become one of the most common gynecological malignant neoplasms in developed countries worldwide. Studies have shown that this may be closely related to the abnormal metabolism o...

    Authors: Wenzhe Li, Yi Xu, Xinling Zeng, Jie Tan, Ya Wang, Hongyan Wu, Maokun Li and Cunjian Yi
    Citation: Lipids in Health and Disease 2023 22:116
  15. Recent insights suggest that remnant cholesterol (RC) plays a role in cellular senescence, yet its specific contribution to frailty remains indeterminate. Through the integration of observational and mendelian...

    Authors: Yuanlong Hu, Xiaojie Wang, Lin Lin, Jiaming Huan, Yuan Li, Lei Zhang and Yunlun Li
    Citation: Lipids in Health and Disease 2023 22:115
  16. Glioblastoma (GBM) is a highly aggressive and lethal brain tumor with limited treatment options, such as the chemotherapeutic agent, temozolomide (TMZ). However, many GBM tumors develop resistance to TMZ, whic...

    Authors: Tzu-Jen Kao, Chien-Liang Lin, Wen-Bin Yang, Hao-Yi Li and Tsung-I Hsu
    Citation: Lipids in Health and Disease 2023 22:114
  17. Authors: Solim Essomandan Clémence Bafei, Xianghai Zhao, Changying Chen, Junxiang Sun, Qian Zhuang, Xiangfeng Lu, Yanchun Chen, Xincheng Gu, Fangyuan Liu, Jialing Mu, Lai Wei, Pengfei Wei, Yunjie Yin, Hankun Xie, Song Yang and Chong Shen
    Citation: Lipids in Health and Disease 2023 22:113

    The original article was published in Lipids in Health and Disease 2023 22:95

  18. Dihydromyricetin (DMY) is a natural flavonoid with anti-nonalcoholic steatohepatitis (NASH) activity. However, the effects of DMY on the composition of lipids and bile acids (BAs) in serum, and gut microbiota ...

    Authors: Xiaolei Miao, Ping Luo, Jiao Liu, Junjun Wang and Yong Chen
    Citation: Lipids in Health and Disease 2023 22:112
  19. Evidence exists of a strong association between inflammation and a decrease in skeletal muscle function and bone mineral density (BMD); however, the specific mechanisms of these associations remain unclear. Ad...

    Authors: Wenhao Wang, Xuchao Gu, Ziyi Cao, Xiaojun Wang, Yiming Lei, Xiaoli Xu, Shiwen Wang, Tao Wu and Zhijun Bao
    Citation: Lipids in Health and Disease 2023 22:111
  20. A previous study demonstrated that low-density lipoprotein cholesterol (LDL-C) is associated with hepatocellular carcinoma (HCC); however, the causality between them has not been proven due to conflicting rese...

    Authors: Jiali Cao, Ziwen Wang, Mengpei Zhu, Yumei Huang, Ze Jin and Zhifan Xiong
    Citation: Lipids in Health and Disease 2023 22:110
  21. The prevalence of microvascular complications in type 2 diabetes mellitus (T2DM) is increasing. The effect of lipid profiles on diabetic microvascular complications remains debated. This research aimed to stud...

    Authors: Jiahang Li, Lei Shi, Guohong Zhao, Fei Sun, Zhenxing Nie, Zhongli Ge, Bin Gao and Yan Yang
    Citation: Lipids in Health and Disease 2023 22:109
  22. There is an urgent need to learn more about the epidemiological features of dyslipidemia in youth to address the high burden of cardiovascular disease.

    Authors: Liang-Yu Liu, Xiyidan Aimaiti, Ying-Ying Zheng, Xiao-Yu Zhi, Zhi-Long Wang, Xin Yin, Ying Pan, Ting-Ting Wu and Xiang Xie
    Citation: Lipids in Health and Disease 2023 22:108
  23. Thermoxidation of edible oil through deep fat frying results in the generation of several oxidized products that promote lipid peroxidation and ROS production when eaten. Consumption of thermoxidized oil in po...

    Authors: Joy Temiloluwa Folahan, Olufunke Esan Olorundare, Abayomi Mayowa Ajayi, Adeoye Oyetunji Oyewopo, Sunday Sokunle Soyemi, Adejuwon Adewale Adeneye, Ikechukwu Innocent Okoye, Saheed Olanrewaju Afolabi and Anoka Ayembe Njan
    Citation: Lipids in Health and Disease 2023 22:107
  24. Body fat composition is believed to be associated with the progression, medical response, and prognosis of inflammatory bowel disease (IBD). Hence, we conducted this study to explore if fat metrics were associ...

    Authors: Shubei He, Yuxia Huang, Ying Peng, Jin Chai and Kun Chen
    Citation: Lipids in Health and Disease 2023 22:106
  25. Studies have shown that the lipid metabolism mediator leukotriene and prostaglandins are associated with the pathogenesis of allergic rhinitis (AR). The aim of this study was to identify key lipid metabolism-r...

    Authors: Qilei Tao, Yajing Zhu, Tianyu Wang, Yue Deng, Huanhai Liu and Jian Wu
    Citation: Lipids in Health and Disease 2023 22:105

    The Correction to this article has been published in Lipids in Health and Disease 2023 22:118

  26. Generally, low-density lipoprotein (LDL) particle size can be inferred from the LDL cholesterol concentration to total apolipoprotein B concentration ratio (LDL-C/ApoB ratio, hereinafter called LAR), which is ...

    Authors: Li Xiao, Kerui Zhang, Fang Wang, Min Wang, Qingxia Huang, Chenchen Wei and Zhongshan Gou
    Citation: Lipids in Health and Disease 2023 22:104
  27. Oxylipins are derived from enzymatic and non-enzymatic oxidation of n-3 and n-6 long-chain polyunsaturated fatty acids. They are known to be involved in inflammatory processes. The aim of this study was to descri...

    Authors: Hélène Fougère, Karine Greffard, Mireille Guillot, Iwona Rudkowska, Etienne Pronovost, David Simonyan, Isabelle Marc and Jean-François Bilodeau
    Citation: Lipids in Health and Disease 2023 22:103
  28. Increased levels of low-density lipoprotein cholesterol (LDL-C) have been identified as one potential risk factor for diabetic peripheral neuropathy (DPN) in patients. The current study seeks to clarify the li...

    Authors: Hui Zhang, Yang Chen, Wenwen Zhu, Tong Niu, Bing Song, Hongxiao Wang, Wei Wang and Haoqiang Zhang
    Citation: Lipids in Health and Disease 2023 22:102
  29. In light of the high prevalence of nonalcoholic fatty liver disease and obesity, treatment options for nonalcoholic steatohepatitis are of particular interest. The purpose of the study is to assess the efficac...

    Authors: Natalia Zakharova, Chenguang Luo, Raisa Aringazina and Vadim Samusenkov
    Citation: Lipids in Health and Disease 2023 22:101
  30. Prevention measures for cardiovascular diseases (CVD) have shifted their focus from lipoproteins to the immune system. However, low-grade inflammation and dyslipidemia are tightly entangled. The objective of t...

    Authors: Daniel L. Pontzen, Martin Bahls, Diana Albrecht, Stephan B. Felix, Marcus Dörr, Till Ittermann, Matthias Nauck and Nele Friedrich
    Citation: Lipids in Health and Disease 2023 22:100
  31. Heme oxygenase 1 (HO-1) has an influential but insufficiently investigated effect on ferroptosis, which is a novel form of programmed cell death and may play an effect on nonalcoholic steatohepatitis (NASH). H...

    Authors: Xiwei Yuan, Lu Li, Ying Zhang, Rong Ai, Dongdong Li, Yao Dou, Mengmeng Hou, Dandan Zhao, Suxian Zhao and Yuemin Nan
    Citation: Lipids in Health and Disease 2023 22:99
  32. Apolipoproteins and lipoprotein(a) are associated with various cardiometabolic diseases, including insulin resistance, diabetes mellitus, hypertension, dyslipidemia, among others. This systematic review and me...

    Authors: Juan R. Ulloque-Badaracco, Ali Al-kassab-Córdova, Enrique A. Hernandez-Bustamante, Esteban A. Alarcon-Braga, Miguel Huayta-Cortez, Ximena L. Carballo-Tello, Rosa A. Seminario-Amez, Percy Herrera-Añazco and Vicente A. Benites-Zapata
    Citation: Lipids in Health and Disease 2023 22:98
  33. The common inflammatory disease multiple sclerosis (MS) is a disease of the central nervous system. For more than 25 years autologous hematopoietic stem cell transplantation (AHSCT) has been used to treat MS. ...

    Authors: Aina Vaivade, Anna Wiberg, Payam Emami Khoonsari, Henrik Carlsson, Stephanie Herman, Asma Al-Grety, Eva Freyhult, Ulla Olsson-Strömberg, Joachim Burman and Kim Kultima
    Citation: Lipids in Health and Disease 2023 22:97
  34. Atherosclerosis is now the main cause of cardiac-cerebral vascular diseases around the world. Disturbances in lipid metabolism have an essential role in the development and progression of atherosclerosis. Thus...

    Authors: Xue Pan, Jifeng Liu, Lei Zhong, Yunshu Zhang, Chaosheng Liu, Jing Gao and Min Pang
    Citation: Lipids in Health and Disease 2023 22:96
  35. Dyslipidemia and inflammation are significant factors for the onset of cardiovascular diseases (CVD); however, studies regarding their interactions on the risk of CVD are scarce. This study aimed to assess the...

    Authors: Solim Essomandan Clémence Bafei, Xianghai Zhao, Changying Chen, Junxiang Sun, Qian Zhuang, Xiangfeng Lu, Yanchun Chen, Xincheng Gu, Fangyuan Liu, Jialing Mu, Lai Wei, Pengfei Wei, Yunjie Yin, Hankun Xie, Song Yang and Chong Shen
    Citation: Lipids in Health and Disease 2023 22:95

    The Correction to this article has been published in Lipids in Health and Disease 2023 22:113

  36. Small dense low-density lipoprotein cholesterol (sdLDL-C) is the lipoprotein marker among the various lipoproteins that is most strongly related to atherosclerosis. Insulin resistance (IR) can alter lipid meta...

    Authors: Sanghoon Kim, Ji-Won Lee, Yaeji Lee, Youhyun Song and John A Linton
    Citation: Lipids in Health and Disease 2023 22:94
  37. Obesity-related chronic inflammation is closely related to the ability of immune cells to adapt to the body’s needs, research has shown that excess FAs can further activate pro-inflammatory transcription facto...

    Authors: Su Liqiang, Li Fang-Hui, Quan Minghui, Yang Yanan and Chen Haichun
    Citation: Lipids in Health and Disease 2023 22:93
  38. Lipid metabolism-related genes (LMRGs) have been reported to be correlated with the immune infiltration of colorectal cancer (CRC). This study aimed to investigate the immune infiltration characteristics along...

    Authors: Jie Chen, Jianfang Ye and Renxu Lai
    Citation: Lipids in Health and Disease 2023 22:92
  39. Patients with chronic hepatitis C virus (HCV) infections differ in their risk for metabolic disorders and chronic kidney disease (CKD). The aim of this study was to investigate the effect of metabolic disorder...

    Authors: Jia Liu, Wenqian Qi, Song Wang, Yonggui Zhang, Xu Wang, Derong Sun, Yanhui Xu, Jingyi Shi, Honglei Duan, Qian Zhang, Hongguang Wang and Jiangbin Wang
    Citation: Lipids in Health and Disease 2023 22:91
  40. The Chinese visceral adiposity index (CVAI), a simple surrogate measure of visceral fat, is significantly associated with cardiovascular disease (CVD) risk in the general population. This study aimed to evalua...

    Authors: Yuntao Wu, Wenqi Xu, Lu Guo, Wenjuan Li, Lisha Zhang, Lishu Gao, Chenrui Zhu, Shuohua Chen, Liming Lin and Shouling Wu
    Citation: Lipids in Health and Disease 2023 22:90
  41. High-density lipoproteins (HDLs) have antiatherogenic properties related to their chemical structure. Adipose tissue (AT) influences HDL reverse cholesterol transport and plasma HDL cholesterol levels. However...

    Authors: Esteban Jorge-Galarza, Aida Medina-Urrutia, Juan Reyes-Barrera, Margarita Torres-Tamayo, Luis Felipe Montaño-Estrada, Araceli Páez-Arenas, Felipe Massó-Rojas and Juan Gabriel Juárez-Rojas
    Citation: Lipids in Health and Disease 2023 22:89
  42. As a common malignant tumour, pancreatic cancer (PC) has the worst clinical outcome. Early evaluation of the postoperative prognosis has certain clinical value. Low-density lipoprotein cholesterol (LDL-c), whi...

    Authors: Hanxuan Wang, Yulin Li, Jincan Huang, Youwei Ma, Shaocheng Lyu and Ren Lang
    Citation: Lipids in Health and Disease 2023 22:88
  43. The atherogenic index of plasma (AIP), consisting of triglycerides and high-density lipoprotein cholesterol, is applied to estimate the cardiovascular disease risk. The evidence regarding the association betwe...

    Authors: Mingjuan Tan, Yongliang Zhang, Ling Jin, Youli Wang, Weiwei Cui, Lubanga Nasifu and Bangshun He
    Citation: Lipids in Health and Disease 2023 22:87
  44. The previous study investigated whether the functions of small, medium, and large high density lipoprotein (S/M/L-HDL) are correlated with protein changes in mice. Herein, the proteomic and functional analyses...

    Authors: Canxia Huang, Jie Zhang, Jingjing Huang, Hongwei Li, Kexin Wen, Jinlan Bao, Xiaoying Wu, Runlu Sun, Ayiguli Abudukeremu, Yue Wang, Zhijian He, Qiaofei Chen, Xinyi Huang, Hong Wang and Yuling Zhang
    Citation: Lipids in Health and Disease 2023 22:86
  45. We aim to develop and validate a nomogram including readily available clinical and laboratory indicators to predict the risk of metabolic-associated fatty liver disease (MAFLD) in the Chinese physical examinat...

    Authors: Bingqian Zhou, Ni Gong, Xinjuan Huang, Jingchi Zhu, Chunxiang Qin and Qingnan He
    Citation: Lipids in Health and Disease 2023 22:85
  46. One of the most prevalent sleep disorders affecting the individual’s daily life is obstructive sleep apnea (OSA), for which obesity is a major risk factor. Several novel lipid indices have been suggested to ha...

    Authors: Amir Hossein Behnoush, Pegah Bahiraie, Zahra Shokri Varniab, Laleh Foroutani and Amirmohammad Khalaji
    Citation: Lipids in Health and Disease 2023 22:84
  47. Population-based studies investigating the association between blood coagulation markers and non-alcoholic fatty liver disease (NAFLD) are rare. Thus, we aimed to investigate the relationship between the Fatty...

    Authors: Maximilian Iglesias Morcillo, Dennis Freuer, Anette Peters, Margit Heier, Daniel Teupser, Christine Meisinger and Jakob Linseisen
    Citation: Lipids in Health and Disease 2023 22:83
  48. Twenty-three percent of patients are diagnosed with diabetes mellitus after the first episode of acute pancreatitis. The incidence of post-acute pancreatitis diabetes mellitus is significantly higher than that...

    Authors: Xiamin Tu, Qingxie Liu, Lin Chen, Jie Li, Xiaoping Yu, Xiuping Jiao, Ningzhi Wang, Lianghao Hu, Yuan Yuan, Weijuan Gong, Yanbing Ding, Xiaolei Shi, Weiming Xiao and Guotao Lu
    Citation: Lipids in Health and Disease 2023 22:82

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    68 days submission to accept (Median)

    2023 Usage 
    1,810,907 downloads
    1,488 Altmetric mentions